Objective: To compare the differences of anti-allergic drugs in National Essential Medicines List (NEML)

World Health Organization (WHO) Model List of Essential Medicines for Children (WHO-EMLc) and other 19 national essential medicines lists

so as to provide reference for further improving the essential medicines list of China. Methods: WHO official website was searched to collect essential medicines list in different countries. Through Excel analysis

differences in the types

quantities

dosage forms and specifications of anti-allergic drugs were compared

the suitability of essential medicines for children was discussed

and the listing of anti-allergic drugs in China was summarized. Results: Loratadine was the same anti-allergic drug in WHO-EMLc and NEML. Compared with NEML

WHO-EMLc and other 19 national essential medicines lists added the oral solution in children

and some countries indicated the age limit of chlorpheniramine and cetirizine. The dosage forms of anti-allergic drugs included in the lists were mainly ordinary tablets. Granules

syrups for children and other special formulations were listed

yet there were few manufacturers. Conclusion: Based on NEML and WHO-EMLc

and drawing on the experience of Sweden

Malaysia

Maldives and other countries

it is recommended to appropriately increase the dosage forms and specifications of second-generation antihistamines suitable for children

so as to to ensure the safety and effectiveness of clinical use in children and improve the national essential medicines list